Sciformix, a US-headquartered Scientific Process Organisation (SPO), has opened an office in Manila, the Philippines.
The expansion is part of Sciformix’s continued growth and will add more than 200 skilled staff. The firm now has operations in the US, India and the Philippines.
‘Sciformix’s continued growth and success has created an opportunity for our expansion into Manila, which is an important piece of our strategy and global footprint,’ said Manish Soman, President and Chief Executive of Sciformix.
With this expansion into the Philippines, Sciformix claims to be the first company in Manila to undertake case management activities. A 135-strong team from the firm’s Philippines and India centres is supporting one of its clients that specialises in consumer healthcare, medical devices and diagnostics, and pharmaceuticals.
Sciformix forms partnerships with life science organisations across the entire drug development cycle to provide a full range of services from study design to post marketing surveillance and commercialisation support. Areas of specialisation include safety and risk management, clinical research and post approval services, medical affairs, scientific writing and regulatory affairs.
